StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Monday morning. The firm issued a hold rating on the stock.
China Pharma Stock Performance
Shares of NYSE:CPHI opened at $0.24 on Monday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.24 and a current ratio of 0.84. China Pharma has a 52 week low of $0.17 and a 52 week high of $1.16. The company has a 50-day moving average price of $0.22 and a 200 day moving average price of $0.26.
China Pharma (NYSE:CPHI – Get Free Report) last issued its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%. The company had revenue of $0.93 million during the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- Buy P&G Now, Before It Sets A New All-Time High
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Why Are These Companies Considered Blue Chips?
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
